::: 큐라티스 :::

Quratis

We hope to become a company with a social impact that leads the human public health.

2020

10

· Selection of the development of vaccine commercialization technology project
by Ministry of Health Welfare
09

· Completion of Osong Bio Plant (GMP facility) Construction
07

· KIAT 2020 BIG3 SMEs selection of innovative growth support tasks
06

· Development of Prime-Boost TB vaccines by Chungnam National University,
Yonsei University, Quratis and Institut Pasteur were selected as project supported
by RIGHT Fund
06

· Selection of industry-academic Collabo R&D project
by Ministry of SMEs and Startups
06

· Selection of startup scale-up package by Ministry
of SMEs and Startups
06

· Capital increase KRW 10.84 Billion
01

· Phase 1 TB vaccine in adolescents: interim results completed
01

· Selection of research driven hospital promotion R&D project
by Ministry of Health Welfare

2019

12

· 2019 Grand Prize for Technology Innovation from Minister,
Ministry of SMEs and Startups
12

· 2019 Grand Prize for Bio from Ministry of Trade,
Industry and Energy
10

· Selection of a porcine circovirus vaccine development
project proposed by the Seoul Business Agency
08

· Phase 2a TB vaccine in adults: interim results completed
06

· Selection of antibiotic-resistant antimicrobial agent project
supported by the Ministry of SMEs and Startups
05

· Start of Osong plant construction
01

· Selection of formulation development project in Cheombok Complex

2018

2017

2016